During the past decade, Japanese Red Cross Nagoya Daiichi Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Japanese Red Cross Nagoya Daiichi Hospital" #1 sponsor was "Pfizer" with 4 trials, followed by "Ferring Pharmaceuticals" with 2 trials sponsored, "Society for Advancement of Coronary Intervention Research" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Canadian Cancer Trials Group" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Japanese Red Cross Nagoya Daiichi Hospital" #1 collaborator was "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator, "Chinese Thoracic Oncology Group" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Dutch Society of Physicians for Pulmonology and Tuberculosis" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Nagoya Daiichi Hospital" are "Nocturia" (2 trials), "Rheumatoid Arthritis" (2 trials), "Aspergillosis, Aspergilloma" (1 trials), "Chronic Myelogenous Leukemia" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Japanese Red Cross Nagoya Daiichi Hospital" in a lesser frequency.

Most popular intervention types in "Japanese Red Cross Nagoya Daiichi Hospital" are "Drug" (13 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "A. Desmopressin 10 microgram" (1 trials), "Antithrombin gamma" (1 trials), "B: Desmopressin 25 microgram" (1 trials) and "Best Supportive Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Japanese Red Cross Nagoya Daiichi Hospital" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Japanese Red Cross Nagoya Daiichi Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Japanese Red Cross Nagoya Daiichi Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Japanese Red Cross Nagoya Daiichi Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".